Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 39, 2010 - Issue 4-5
469
Views
21
CrossRef citations to date
0
Altmetric
Research Articles

Transgenic Plant-Based Oral Vaccines

, , &
Pages 468-482 | Published online: 07 May 2010

REFERENCES

  • Akbari, O., DeKruyff, R. H., Umetsu, D. T. (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725–731.
  • Belyakov, I. M., Hammond, S. A., Ahlers, J. D., Glenn, G. M., Berzofsky, J. A. (2004). Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113:998–1007.
  • Bender, B. S., Croghan, T., Zhang, L., Small, P. A., Jr. (1992). Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1143–1145.
  • Bilsborough, J., Viney, J. L. (2004). Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127:300–309.
  • Braunstein, J., Qiao, L., Autschbach, F., Schurmann, G., Meuer, S. (1997). T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 41: 215–220.
  • Buzoni-Gatel, D., Lepage, A. C., Dimier-Poisson, I. H., Bout, D. T., Kasper, L. H. (1997). Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158:5883–5889.
  • Carol, M., Lambrechts, A., Van, G.A., Libin, M., Goldman, M., Mascart-Lemone, F. (1998). Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes. Gut 42:643–649.
  • Chargelegue, D., Drake, P. M., Obregon, P., Prada, A., Fairweather, N., Ma, J. K. (2005). Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infect. Immun. 73:5915–5922.
  • Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., Weiner, H. L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237–1240.
  • Connell, T. D. (2007). Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins. Expert. Rev. Vaccines 6:821–834.
  • Dietrich, G., Spreng, S., Favre, D., Viret, J. F., Guzman, C. A. (2003). Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr. Opin. Mol. Ther. 5:10–19.
  • Dow AgroSciences. (2006). www.dowagro.com/newsroom/corporatenews/2006/20060131b.htm [].
  • Ehrenfeld, E., Modlin, J., Chumakov, K. (2009). Future of polio vaccines. Expert. Rev. Vaccines 8:899–905.
  • European Agency for the Evaluation of Medicinal Products. (2002). Points to Consider on Quality Aspects of Medicinal Products Containing Active Substances Produced by Stable Transgene Expression in Higher Plants. London, UK.
  • Food and Drug Administration (2002). Guidance for Industry: drugs, biologicis, and medical devices derived from bioengineered plants for use in humans and animals. Fed. Reg. 67:57828–57829.
  • Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De, P.M., Brandi, G., Eberl, G., Snel, J., Kelly, D., Cerf-Bensussan, N. (2009). The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677–689.
  • Giritch, A., Marillonnet, S., Engler, C., van, E. G., Botterman, J., Klimyuk, V., and Gleba, Y. (2006). Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl. Acad. Sci. USA 103: 14701–14706.
  • Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., Roncarolo, M. G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742.
  • Hanninen, A., Harrison, L.C. (2000). Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173:109–119.
  • Holmgren, J., Adamsson, J., Anjuere, F., Clemens, J., Czerkinsky, C., Eriksson, K., Flach, C.F., George-Chandy, A., Harandi, A.M., Lebens, M., Lehner, T., Lindblad, M., Nygren, E., Raghavan, S., Sanchez, J., Stanford, M., Sun, J. B., Svennerholm, A. M., Tengvall, S. (2005). Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 97:181_188.
  • Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K., Littman, D.R. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498.
  • Iwasaki, A., Kelsall, B.L. (1999). Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190:229–239.
  • Jiang, X. L., He, Z. M., Peng, Z. Q., Qi, Y., Chen, Q., and Yu, S. Y. (2007). Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice. Transgenic Res. 16:169–175.
  • Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., Legocki, A. B. (1999). A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13:1796–1799.
  • Kapusta, J., Modelska, A., Pniewski, T., Figlerowicz, M., Jankowski, K., Lisowa, O., Plucienniczak, A., Koprowski, H., Legocki, A.B. (2001). Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv. Exp. Med. Biol. 495:299–303.
  • Klein, L., Khazaie, K., von, B.H. (2003). In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886–8891.
  • Kohl, T. O., Hitzeroth, I. I., Christensen, N. D., Rybicki, E. P. (2007). Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC. Biotechnol. 7:56.
  • Kong, Q., Richter, L., Yang, Y.F., Arntzen, C.J., Mason, H.S., Thanavala, Y. (2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 98:11539–11544.
  • Koya, V., Moayeri, M., Leppla, S. H., Daniell, H. (2005). Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73:8266–8274.
  • Kumar, G. B., Ganapathi, T. R., Revathi, C. J., Srinivas, L., Bapat, V. A. (2005). Expression of hepatitis B surface antigen in transgenic banana plants. Planta 222:484–493.
  • Lamphear, B. J., Jilka, J. M., Kesl, L., Welter, M., Howard, J. A., Streatfield, S. J. (2004). A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22:2420–2424.
  • Lavelle, E. C., O'Hagan, D.T. (2006). Delivery systems and adjuvants for oral vaccines. Expert. Opin. Drug Deliv. 3:747–762.
  • Lefrancois, L., Olson, S., Masopust, D. (1999). A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J. Exp. Med. 190:1275–1284.
  • Lelouard, H., Henri, S., De, B. B., Mugnier, B., Chollat-Namy, A., Malissen, B., Meresse, S., Gorvel, J. P. (2009). Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's Patch dendritic cells that express lysozyme. Gastroenterology. 138:173–184.
  • Lewis, G. K. (2007). Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Expert. Rev. Vaccines 6:431–440.
  • Mason, H. S., Ball, J. M., Shi, J. J., Jiang, X., Estes, M. K., Arntzen, C. J. (1996). Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93:5335–5340.
  • Mason, H. S., Haq, T. A., Clements, J. D., Arntzen, C. J. (1998). Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336–1343.
  • Mason, H. S., Lam, D. M., Arntzen, C. J. (1992). Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89:11745–11749.
  • Mason, H. S., Warzecha, H., Mor, T., Arntzen, C. J. (2002). Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8: 324–329.
  • McCluskie, M. J. Davis, H. L. (2000). Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413–422.
  • McCluskie, M. J., Weeratna, R. D., Krieg, A. M., Davis, H. L. (2000). CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine 19:950–957.
  • Mestecky, J., Nguyen, H., Czerkinsky, C., Kiyono, H. (2008). Oral immunization: an update. Curr. Opin. Gastroenterol. 24:713–719.
  • Mowat, A. M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331–341.
  • Mowat, A. M. (2005). Dendritic cells and immune responses to orally administered antigens. Vaccine 23:1797–1799.
  • Mowat, A. M., Millington, O. R., Chirdo, F. G. (2004). Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr. Gastroenterol. Nutr. 39 Suppl 3:S723–S724.
  • Nawar, H. F., Arce, S., Russell, M. W., Connell, T. D. (2005). Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. Infect. Immun. 73:1330–1342.
  • O'Hagan, D.T., Rappuoli, R. (2004). Novel approaches to vaccine delivery. Pharm. Res. 21:1519–1530.
  • Pascual, D. W., Powell, R. J., Lewis, G. K., Hone, D. M. (1997). Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine. Behring Inst. Mitt. 143–152.
  • Peppoloni, S., Ruggiero, P., Contorni, M., Morandi, M., Pizza, M., Rappuoli, R., Podda, A., Del, G. G. (2003). Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Expert. Rev. Vaccines. 2:285–293.
  • Polanski, M., Melican, N. S., Zhang, J., Weiner, H. L. (1997). Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10:339–346.
  • Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241.
  • Richter, L. J., Thanavala, Y., Arntzen, C. J., Mason, H. S. (2000). Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18:1167–1171.
  • Roelofs-Haarhuis, K., Wu, X., Gleichmann, E. (2004). Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173:1043–1050.
  • Staats, H. F., Bradney, C. P., Gwinn, W. M., Jackson, S. S., Sempowski, G. D., Liao, H.X., Letvin, N. L., Haynes, B. F. (2001). Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J. Immunol. 167:5386–5394.
  • Stassen, M., Fondel, S., Bopp, T., Richter, C., Muller, C., Kubach, J., Becker, C., Knop, J., Enk, A. H., Schmitt, S., Schmitt, E., Jonuleit, H. (2004). Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol. 34:1303–1311.
  • Stephenson, I., Zambon, M. C., Rudin, A., Colegate, A., Podda, A., Bugarini, R., Del, G. G., Minutello, A., Bonnington, S., Holmgren, J., Mills, K. H., Nicholson, K. G. (2006). Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J. Virol. 80:4962–4970.
  • Strasser, R., Castilho, A., Stadlmann, J., Kunert, R., Quendler, H., Gattinger, P., Jez, J., Rademacher, T., Altmann, F., Mach, L., Steinkellner, H. (2009). Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J. Biol. Chem. 284:20479–20485.
  • Strobel, S., Mowat, A. M. (1998). Immune responses to dietary antigens: oral tolerance. Immunol. Today 19:173–181.
  • Summerton, N. A., Welch, R. W., Bondoc, L., Yang, H. H., Pleune, B., Ramachandran, N., Harris, A. M., Bland, D., Jackson, W. J., Park, S., Clements, J. D., Nabors, G. S. (2009). Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine. 28(5):1404–1411.
  • Tacket, C. O. (2004). Garden-variety vaccines: antigens derived from transgenic plants. Expert. Rev. Vaccines 3:529–531.
  • Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., Arntzen, C. J. (1998). Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:607–609.
  • Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M., Arntzen, C. J. (2000). Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis.182:302–305.
  • Thanavala, Y., Huang, Z., Mason, H. S. (2006). Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert. Rev. Vaccines 5:249–260.
  • Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C. J., Mason, H. S. (2005). Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. USA 102:3378–3382.
  • Thanavala, Y., Yang, Y. F., Lyons, P., Mason, H. S., Arntzen, C. (1995). Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92:3358–3361.
  • Thornton, A. M. Shevach, E. M. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287–296.
  • Tiwari, S., Verma, P.C., Singh, P. K., Tuli, R. (2009). Plants as bioreactors for the production of vaccine antigens. Biotechnol. Adv. 27:449–467.
  • Tsuji, T., Honda, T., Miwatani, T., Wakabayashi, S., Matsubara, H. (1985). Analysis of receptor-binding site in Escherichia coli enterotoxin. J. Biol. Chem. 260:8552–8558.
  • von, B.H. (2007). Oral tolerance: is it all retinoic acid? J. Exp. Med. 204:1737–1739.
  • Walker, L. S., Chodos, A., Eggena, M., Dooms, H., Abbas, A.K. (2003). Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198: 249–258.
  • Warzecha, H., Mason, H. S., Lane, C., Tryggvesson, A., Rybicki, E., Williamson, A. L., Clements, J. D., and Rose, R. C. (2003). Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol. 77:8702–8711.
  • Watson, J., Koya, V., Leppla, S. H., Daniell, H. (2004). Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22:4374–4384.
  • Yang, Z. Q., Liu, Q. Q., Pan, Z. M., Yu, H. X., Jiao, X. A. (2007). Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice. Vaccine 25:591–598.
  • Yu, J, Langridge, W. H. (2001). A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 19:548–552.
  • Yuan, Q., Walker, W. A. (2004). Innate immunity of the gut: mucosal defense in health and disease. J. Pediatr. Gastroenterol. Nutr. 38:463–473.
  • Yuki, Y., Kiyono, H. (2009). Mucosal vaccines: novel advances in technology and delivery. Expert. Rev. Vaccines 8:1083–1097.
  • Zhou, J. Y., Wu, J. X., Cheng, L. Q., Zheng, X. J., Gong, H., Shang, S. B., Zhou, E. M. (2003). Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes. J. Virol. 77:9090–9093.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.